| Pharmaceutical active ingredients: |
| Oxolamine CitratePropyphenazone |
| Available forms, composition and doses of Fargepirina: |
| N / A |
| Fargepirina medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB54 - Propyphenazone, combinations excluding psycholepticsR05DB07 - Oxolamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| UPSA Laboratoires |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Gantrimex | Oxolamine Citrate; Oxolamine Phosphate | Geymonat |
| Lexo | Oxolamine Citrate; Oxolamine Phosphate | Flupal Laboratorios |
| Oxolam | Oxolamine Citrate; Oxolamine Phosphate | Quim-Far Laboratorios |
| Perebron | Oxolamine Citrate; Oxolamine Phosphate | Elmor Laboratorios; Angelini; Chile Laboratorios; Farma Lepori |
| Respibron | Oxolamine Citrate; Oxolamine Phosphate | Andromaco Laboratorios |
| Uniplus Suppositories | Oxolamine Citrate; Propyphenazone | Angelini |
| Upsa Plus | Oxolamine Citrate; Propyphenazone | Bristol-Myers Squibb; UPSA Laboratoires |
| Pulmotrim | Oxolamine Citrate; Sulfamethoxazole; Trimethoprim | Farge |
| Exeton | Oxolamine Phosphate | Andromaco Laboratorios |
| Oxalcor | Oxolamine Phosphate | Corporacion de Salud |